Clinical Trial Update: The Optimal Intervention Time of Radiotherapy for Oligometastatic Stage IV Non-small Cell Lung Cancer（NSCLC） [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating optimal timing of radiotherapy in oligometastatic stage IV non-small cell lung cancer is ongoing, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Sichuan Cancer Hospital and Research Institute | Conditions: Oligo-metastatic Stage IV Non-small Cell Lung Cancer | Phase 3 | Status: UNKNOWN